Standard Therapy;
Levetiracetam;
Seizure Frequency;
Epilepsy Surgery;
Refractory Epilepsy;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Objectives: This study provides the results of a cost-effectiveness analysis of levetiracetam as an adjunctive treatment for refractory epilepsy from the Canadian Ministry of Health perspective. The main objective is to estimate the expected cost-effectiveness ratio expressed as the incremental cost per seizure-free day gained when using levetiracetam. In addition, this study examines the potential savings that might result by reducing the number of surgical evaluations and surgery when using levetiracetam.
机构:
Hallym Univ, Med Ctr, Hangang Sacred Heart Hosp, Dept Psychiat, Seoul 150030, South KoreaHallym Univ, Med Ctr, Hangang Sacred Heart Hosp, Dept Psychiat, Seoul 150030, South Korea
Suh, Guk-Hee
Lee, Sang Keol
论文数: 0引用数: 0
h-index: 0
机构:
Hallym Univ, Med Ctr, Hangang Sacred Heart Hosp, Dept Psychiat, Seoul 150030, South KoreaHallym Univ, Med Ctr, Hangang Sacred Heart Hosp, Dept Psychiat, Seoul 150030, South Korea